Brittany Knick Ragon, Clinical Associate Professor at Wake Forest University School of Medicine, shared a post by DAVA Oncology, on X, adding:
“This was a session on resilience and the relentless pursuit to help our patients with one of the most evasive and cleverest of cancers – deserving of this spotlight (and right on time, to the second)!!”
Quoting DAVA Oncology’s post:
“Starting Now: Cellular Therapies in Development for AML
Moderated by Brittany Knick Ragon.”
Source: Brittany Knick Ragon/X and DAVA Oncology/X